Kiniksa Pharmaceuticals International (KNSA) Change in Acquisitions & Divestments (2018 - 2026)

Kiniksa Pharmaceuticals International (KNSA) has 9 years of Change in Acquisitions & Divestments data on file, last reported at $36.7 million in Q2 2026.

• Quarterly Change in Acquisitions & Divestments rose 19.92% year-over-year to $36.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $307.2 million (up 46.12% YoY) and the FY2025 annual result came in at $199.5 million, down 16.86% from the prior year.
• Change in Acquisitions & Divestments fell to $36.7 million in Q2 2026, from $145.7 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $145.7 million in Q1 2026 to a low of $7.5 million in Q1 2022.
• A 5-year average of $51.4 million and a median of $43.2 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments slumped 94.61% — and 2024, when it surged 312.56%.
• Tracing KNSA's Change in Acquisitions & Divestments over 5 years: stood at $20.1 million in 2022, then soared by 128.75% to $46.0 million in 2023, then surged by 90.26% to $87.5 million in 2024, then slumped by 53.38% to $40.8 million in 2025, then decreased by 10.0% to $36.7 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $36.7 million (Q2 2026), $145.7 million (Q1 2026), and $40.8 million (Q4 2025), per Business Quant data.